$18.76
0.91%
Nasdaq, Sep 28, 04:09 pm EDT. Closed.
ISIN
US8257041090
Symbol
SIBN

SI-BONE, Inc. Target price 2026 - Analyst rating & recommendation

SI-BONE, Inc. Classifications & Recommendation

Buy
94%
Hold
6%

SI-BONE, Inc. Price Target

Target Price $24.48
Price $18.76
Potential
Number of Estimates 12
12 Analysts have issued a price target SI-BONE, Inc. 2027 . The average SI-BONE, Inc. target price is $24.48. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 16 analysts: 15 Analysts recommend SI-BONE, Inc. to buy, 1 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the SI-BONE, Inc. stock has an average upside potential 2027 of . Most analysts recommend the SI-BONE, Inc. stock at Purchase.

Sales and Margin forecast 2026, 2027 & 2028

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Quarter Annually
Dec '25 2026
Estimates
Revenue Million $ 200.93 236.68
20.19% 17.79%
EBITDA Margin -8.24% 5.52%
55.37% 166.98%
Net Margin -9.41% -7.65%
49.13% 18.67%

12 Analysts have issued a sales forecast SI-BONE, Inc. 2026 . The average SI-BONE, Inc. sales estimate is

$237m
unlock
. This is
10.81% higher
unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$244m 14.42%
unlock
, the lowest is
$227m 6.21%
unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2025 $201m 20.19%
2026
$237m 17.79%
unlock
2027
$274m 15.68%
unlock
2028
$316m 15.57%
unlock

11 Analysts have issued an SI-BONE, Inc. EBITDA forecast 2026. The average SI-BONE, Inc. EBITDA estimate is

$13.1m
unlock
. This is
215.23% higher
unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$14.9m 231.52%
unlock
, the lowest is
$10.1m 189.09%
unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2025 $-16.6m 46.36%
2026
$13.1m 178.83%
unlock
2027
$20.6m 57.45%
unlock
2028
$32.7m 59.08%
unlock

EBITDA Margin

2025 -8.24% 55.37%
2026
5.52% 166.98%
unlock
2027
7.51% 36.05%
unlock
2028
10.33% 37.55%
unlock

12 SI-BONE, Inc. Analysts have issued a net profit forecast 2026. The average SI-BONE, Inc. net profit estimate is

$-18.1m
unlock
. This is
23.79% lower
unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$-16.9m 15.52%
unlock
, the lowest is
$-19.7m 34.72%
unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2025 $-18.9m 38.85%
2026
$-18.1m 4.18%
unlock
2027
$-14.9m 17.56%
unlock
2028
$-8.0m 46.28%
unlock

Net Margin

2025 -9.41% 49.13%
2026
-7.65% 18.67%
unlock
2027
-5.45% 28.76%
unlock
2028
-2.54% 53.39%
unlock

Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 & 2028

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Quarter Annually
Dec '25 2026
Estimates
Earnings Per Share $ -0.44 -0.41
41.33% 6.82%
P/E negative
EV/Sales 3.09

12 Analysts have issued a SI-BONE, Inc. forecast for earnings per share. The average SI-BONE, Inc. EPS is

$-0.41
unlock
. This is
24.24% lower
unlock
than earnings per share in the financial year 2025. The highest EPS forecast is
$-0.38 15.15%
unlock
, the lowest is
$-0.44 33.33%
unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2025 $-0.44 41.33%
2026
$-0.41 6.82%
unlock
2027
$-0.33 19.51%
unlock
2028
$-0.18 45.45%
unlock

P/E ratio

Current -56.85 126.58%
2026
-46.31 18.54%
unlock
2027
-56.16 21.27%
unlock
2028
-104.50 86.08%
unlock

Based on analysts' sales estimates for 2026, the SI-BONE, Inc. stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 3.42 27.61%
2026
3.09 9.75%
unlock
2027
2.67 13.56%
unlock
2028
2.31 13.47%
unlock

P/S ratio

Current 3.94 20.31%
2026
3.55 9.75%
unlock
2027
3.07 13.56%
unlock
2028
2.66 13.47%
unlock

Current SI-BONE, Inc. Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
Truist Securities
Locked
➜
Locked
Locked Aug 04 2026
TD Cowen
Locked
➜
Locked
Locked Aug 04 2026
UBS
Locked
➜
Locked
Locked Aug 04 2026
UBS
Locked
➜
Locked
Locked Jul 28 2026
Truist Securities
Locked
➜
Locked
Locked Jul 16 2026
Truist Securities
Locked
➜
Locked
Locked May 12 2026
TD Cowen
Locked
➜
Locked
Locked May 12 2026
Analyst Rating Date
Locked
Truist Securities:
Locked
➜
Locked
Aug 04 2026
Locked
TD Cowen:
Locked
➜
Locked
Aug 04 2026
Locked
UBS:
Locked
➜
Locked
Aug 04 2026
Locked
UBS:
Locked
➜
Locked
Jul 28 2026
Locked
Truist Securities:
Locked
➜
Locked
Jul 16 2026
Locked
Truist Securities:
Locked
➜
Locked
May 12 2026
Locked
TD Cowen:
Locked
➜
Locked
May 12 2026

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today